News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Merck announces positive results for KEYNOTE-756
Photo from Paolo Tarantino/Twitter
Jul 30, 2023, 06:33

Merck announces positive results for KEYNOTE-756

In a post by Paolo Tarantino on Twitter, it says, “Merck announces positive results for KEYNOTE-756: the addition of pembrolizumab to neoadjuvant chemo significantly improved pCR rate among patients with high-risk HR+/HER2- breast cancer. Follow up ongoing for EFS (co-primary endpoint).”

For the article: Click here
Source:Paolo Tarantino / Twitter

Breast Cancer cancer Merck Neoadjuvant OncoDaily Oncology Paolo Tarantino pembrolizumab
Special Coverage
Voices
Sep 8, 2025, 09:53
David Planchard Highlights FLAURA2 OS Benefit Discussion at WCLC 2025
Science
Sep 8, 2025, 09:46
Amol Akhade: WCLC25 Highlight - HARMONi-A Trial in EGFR-mutant NSCLC
Science
Sep 8, 2025, 09:35
Drew Moghanaki: Shift in Radiation Therapy Intent for NSCLC Over the Past Decade
Science
Sep 8, 2025, 09:23
Bassam Sonbol: Randomized Phase II Trial of Pazopanib vs Placebo in Extrapancreatic NETs
Science
Sep 8, 2025, 09:06
Pat Soon-Shiong: Allowing Immune System to Cure the Cancer
Insight
Sep 8, 2025, 08:57
Andreas Charalambous: New Lancet Commission for Lung Cancer
Voices
Sep 8, 2025, 08:51
Roberto Ferrara: Tailoring Combination Treatments to ICI Resistance and Biomarkers
Voices
Sep 8, 2025, 08:44
Katy Beckermann: Strong Correlation Between Uptake and Tissue FAP Expression
Science
Sep 8, 2025, 08:34
Overall Survival with Amivantamab–Lazertinib in EGFR-Mutated Advanced NSCLC
Voices
Sep 8, 2025, 08:22
Vun-Sin Lim Highlights New IASLC Journals Lounge at WCLC25
Voices
Sep 8, 2025, 08:21
Ravindran Kanesvaran: The Best of Collaborative GU Oncology Education
Voices
Sep 8, 2025, 08:19
Harpreet Singh Showcases Biotech on the Main Stage at WCLC2025